Unknown

Dataset Information

Plasma proteomic signatures of liver steatosis and fibrosis in people living with HIV: a cross-sectional study.


ABSTRACT:

Background

Insights into the mechanisms driving metabolic dysfunction-associated steatotic liver disease (MASLD) in people living with HIV (PLHIV) remain limited. Plasma proteomics holds promise for biomarker discovery and the elucidation of biological mechanisms.

Methods

We performed cross-sectional analyses on data from 1036 virally suppressed PLHIV using antiretroviral treatment (ART) from the Dutch multi-centre 2000HIV cohort. Participants underwent transient elastography to assess liver steatosis (controlled attenuation parameter (CAP) ≥263 dB/m) and -fibrosis (liver stiffness measurement (LSM) ≥7.0 kPa). Plasma protein concentrations (n = 2367) (Olink® Explore Panel) were compared between PLHIV with vs. without liver steatosis and PLHIV with vs. without fibrosis. Enric

SUBMITTER: van Eekeren LE 

PROVIDER: S-EPMC11513669 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature